Labcorp names Thomas Pike as president and CEO of clinical development business spin-off

Labcorp's planned spin-off of its clinical development business has a leader – Thomas Pike, an industry veteran with more than 30 years of experience.

Claimants file involuntary Chapter 7 against Nello Construction

Keller Williams partners with Offerpad to offer iBuyer service for faster home sales

Private credit funding tops $70B in Florida

New projects in North Texas (11/30/2022)

UAB School of Engineering plans relocation

New Champion Brands partnership opens channels for Southern craft beer

First look: second location for Back to the Foodture scheduled to open in new year

Exclusive: Indiana developer Garrett Cos. cancels Disney-area project on Westgate-owned land

Labcorp names Thomas Pike as president and CEO of clinical development business spin-off

Previous Ex-Raleigh financier tries to maneuver his way out of prison, again

Next New investments push KeyCare Series A to more than $27M

firststargroup

Kotek touts $500M Oregon housing plan at Leadership Summit

Retirement plans see boost as states mandate IRAs and tax credits lower costs

Norton Healthcare data breach affected more than 2 million people

Houston-based cell therapy company FibroBiologics files to go public

Suggested Posts

Google accelerator helps Chicago tech startup Mozaic land $20 million

Biz: Summer brings Triangle restaurant specials

How Dallas-based Take Command Health raised $25M despite a slowdown for VC

Thrive Med Spa helps patients ‘feel and look good’

Alexander turns to the outdoors to unwind

How unaffordable is RI? The median income isn’t enough for any ZIP codes

MENU

FirstStar Group

More Stories

Boom times to closing time: How Charlotte’s restaurant scene is adjusting to market forces

Previous Ex-Raleigh financier tries to maneuver his way out of prison, again

Next New investments push KeyCare Series A to more than $27M

firststargroup

Related Posts

Suggested Posts

MENU

FirstStar Group

More Stories